
Penumbra PEN
$ 340.06
0.4%
Quarterly report 2025-Q3
added 11-05-2025
Penumbra Operating Cycle 2011-2026 | PEN
Annual Operating Cycle Penumbra
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 386 | 420 | 422 | 385 | 378 | 389 | 344 | 360 | 354 | 393 | 346 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 422 | 344 | 380 |
Quarterly Operating Cycle Penumbra
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 390 | 380 | 389 | 405 | 318 | 427 | 429 | 411 | 420 | - | 227 | 200 | 383 | 360 | 362 | 379 | 432 | 339 | 402 | 598 | 418 | 363 | 390 | 419 | 342 | 312 | 350 | 340 | 321 | 323 | 360 | 358 | 364 | 305 | 333 | 343 | 386 | 338 | 359 | 410 | 393 | 314 | 157 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 598 | 157 | 363 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
274 | $ 33.23 | 1.9 % | $ 1.47 B | ||
|
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
160 | - | 1.37 % | $ 20.5 M | ||
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.08 | 2.98 % | $ 508 M | ||
|
Apyx Medical Corporation
APYX
|
299 | $ 3.75 | -1.83 % | $ 130 M | ||
|
Alphatec Holdings
ATEC
|
351 | $ 13.37 | 2.06 % | $ 1.91 B | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 4.7 | -1.44 % | $ 175 M | ||
|
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | ||
|
Electromed
ELMD
|
228 | $ 24.35 | 4.46 % | $ 206 M | ||
|
Bio-Rad Laboratories
BIO
|
304 | $ 253.63 | -13.27 % | $ 7.16 B | ||
|
Conformis
CFMS
|
216 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
274 | $ 36.37 | -3.05 % | $ 5.42 K | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
278 | $ 41.78 | 0.26 % | $ 1.29 B | ||
|
Boston Scientific Corporation
BSX
|
184 | $ 74.89 | 1.04 % | $ 110 B | ||
|
Abbott Laboratories
ABT
|
183 | $ 112.43 | 0.86 % | $ 196 B | ||
|
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | ||
|
Delcath Systems
DCTH
|
357 | $ 9.26 | 1.48 % | $ 264 M | ||
|
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
266 | $ 13.4 | 2.76 % | $ 362 M | ||
|
Inogen
INGN
|
86.1 | $ 5.8 | 0.17 % | $ 137 M | ||
|
InMode Ltd.
INMD
|
246 | $ 14.41 | 0.79 % | $ 1.14 B | ||
|
IRadimed Corporation
IRMD
|
308 | $ 100.64 | 0.8 % | $ 1.28 B | ||
|
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
130 | - | - | $ 111 M | ||
|
Pulmonx Corporation
LUNG
|
337 | $ 1.49 | 4.58 % | $ 58.3 M | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Eargo
EAR
|
156 | - | - | $ 10.2 M | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Integer Holdings Corporation
ITGR
|
120 | $ 85.98 | 0.73 % | $ 2.89 B | ||
|
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | ||
|
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
251 | $ 18.55 | 0.03 % | $ 122 M | ||
|
Insulet Corporation
PODD
|
281 | $ 244.13 | 1.37 % | $ 17.1 B | ||
|
Globus Medical
GMED
|
343 | $ 88.42 | 1.38 % | $ 12 B | ||
|
Sintx Technologies
SINT
|
526 | $ 3.0 | 10.29 % | $ 11.2 M |